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ABSTRACT                        A number of different ECTO-NOX forms have been described as being connected 
with aging-related diseases. The constitutive form, CNOX, serves as a terminal oxidase of plasma 
membrane electron transport and functions in the growth process. tNOX is present in addition to 
CNOX on the surface of all cancer cells and contributes to the unregulated growth characteristic 
of cancer cells. An age-related ECTO-NOX, arNOX, generates superoxide and may contribute to 
age-related generation of reactive oxygen species. ECTO-NOX proteins and prions share prop-
erties in common as do amyloid-forming proteins of various neurodegenerative disorders. A 
better understanding of ECTO-NOX proteins may lead to new therapeutic strategies for these 
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The most thoroughly studied involvement of an ECTO-NOX 
protein in disease has been that of tNOX and cancer (Morré 
1998; Cho et al. 2002). More recently tNOX has been shown 
to exhibit properties of a prion and various amyloid gener-
ating proteins of neurodegenerative diseases (Alzheimer’s 
β-amyloid, Parkinson’s α-synuclein). The mouse prion has 
properties in common with NOX proteins (Morré and Morré 
2003; Kim and Morré 2004; Markert et al. 2004). We also 
have described an aging-related ECTO-NOX potentially 
involved in the generation of reactive oxygen species at the 
cell surface.
Methods
The oxidative activity of the ECTO-NOX proteins is most 
often measured from the decrease in A
340
 from the oxidation 
of NADH (or NADPH). With turbid membrane preparations, 
use of a dual beam instrument with the photo multiplier tube 
proximal to the sample, is essential to reduce light scattering 
error in continuous measurements. The Aminco SLM 2000 is 
a double beam, dual wavelength grating instrument designed 
for these types of measurements.
Results and Discussion
tNOX and cancer
The cancer-associated, drug-responsive and constitutively-
activated ECTO-NOX form (designated tNOX) is present 
at the cell surface of invasive human cancers (Morré 1998; 
Cho et al. 2002; Chueh et al. 2004). tNOX is shed into the 
circulation and, together with the cell surface form, provides a 
potential diagnostic drug and vaccine target (Cho et al. 2002). 
The normal constitutive NOX (CNOX) form is hormone- and 
growth factor-regulated and responds to agents that control 
growth and development (Bruno et al. 1992). When a cell 
divides, it must reach some certain minimal size to divide 
again. When one or more NOX proteins are inhibited, cell 
enlargement is slowed or blocked. The resultant small cells 
fail to divide and ultimately undergo programmed cell death 
(apoptosis; Morré and Morré 2003).
The ECTO-NOX form associated with human cancers, 
tNOX, differs from the constitutive form of normal cells 
(CNOX) primarily in that its activities are blocked by qui-
none-site inhibitors many of which have anticancer activity 
(Morré 1998). Examples include adriamycin, the antitumor 
sulfonylureas, the antitumor vanilloids (capsaicin), the prin-
cipal tea catechin, (-)-epigallocatechin-3-gallate, and several 
known differentiating agents including antitumor retinoids, 
sodium phenylacetate and calcitriol. These agents are largely 
without effect on the CNOX activity of normal cells. They 
inhibit both tNOX and growth of cancer cells at potentially 
therapeutic dosage levels without inhibiting CNOX or growth 
of non-cancer cells. Drug inhibition by tNOX has served as 
a defining tNOX characteristic used to guide its isolation 
and molecular characterization. The drug responsive tNOX 
appears to arise as a splice variant from a single tNOX gene 
different from that encoding CNOX and is delivered to the 
cell surface in a processed form. 
NOX proteins are released from cells into the circula-
tion. Sera of cancer patients contain both tNOX and CNOX 
proteins (Morré et al. 1997; Morré and Reust 1997; Cho et al. 
2002). Sera of healthy volunteers or of patients with diseases 
other than cancer contain only the CNOX form. tNOX has 
been found in sera of patients with all major forms of cancer 
including leukemia and lymphomas (Morré et al. 1997; Morré 
and Reust 1997; Cho et al. 2002) and serves as the basis for 
a cancer diagnostic protocol under development.
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ECTO-NOX proteins have characteristics of 
prions
ECTO-NOX proteins and prions share similar properties 
(Kelker et al. 2001). The ability to form insoluble aggregates 
and the presence of bound copper are ECTO-NOX protein 
characteristics (Morré and Morré 2003). Other unusual char-
acteristics exhibited by tNOX and shown with other ECTO-
NOX proteins include resistance to proteases, resistance to 
cyanogen bromide fragmentation, and an ability to form 
amyloid filaments closely resembling those of transmissible 
spongiform encephalopathies. Additionally, tNOX imparts 
protease resistance to a normally protease-susceptible protein 
as is characteristic of PrPsc (PrPres), the presumed infective 
and proteinase K-resistant scrapie prion form. Recombinant 
mouse prion exhibited a copper dependent pattern of oscil-
lating and alternating NADH oxidase and disulfide-thiol 
interchange with a 24 min period indistinguishable from that 
of CNOX (Kim and Morré 2004). 
Aging
An aging-related ECTO-NOX protein (arNOX) of human sera 
and buffy coat fractions of individuals > 60 y with a potential 
role in atherogenesis generates superoxide (Morré et al. 2000; 
2003). Superoxide production capable of oxidizing circulat-
ing lipoproteins and other extracellular targets are measured 
by the reduction of ferricytochrome c. Activity is inhibited 









 do not inhibit. The activity is reduced 
or absent from sera and/or buffy coat fractions of younger 
individuals (20 – 40 y) but appears to be widely distributed 
among other aged systems including late-passage cultured 
cells and senescing plant organs.
The superoxide generated is also active in the reduction 
of tetrazolium salts such as XTT (Na 3’-[(phenylamino)-
carbonyl]-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene 
sulfonic acid) leading to colored formazan formation. Other 
NOX proteins lack this activity.
arNOX proteins (Morré 1998; Morré et al. 1999) and other 
ECTO-NOX proteins (de Grey 1999) have been postulated 
to link the accumulation of lesions in mitochondrial DNA to 
cell surface accumulations of reactive oxygen species as one 
consequence of their role as a terminal oxidase in a plasma 
membrane electron transport chain. Cells with functionally 
deficient mitochondria become characterized by an anaerobic 
metabolism. NADH accumulated from the glycolytic produc-
tion of ATP and an elevated plasma membrane electron trans-
port activity are then necessary to maintain the NAD+/NADH 
homeostasis essential for survival. 
Neurodegenerative disorders
tNOX aggregates in the form of enzymatically inactive amy-
loid rods and open cylinders (rings) were observed by high 
resolution electron microscopy (Kelker et al. 2001). These 
structures were virtually indistinguishable from correspond-
ing aggregates associated with neurodegenerative amyloid-
forming proteins.
Observations were extended to Alzheimer’s Aβ 1-43 
peptide (Markert et al. 2004) and α-synuclein of Parkinson’s 
disease (Morré and Morré 2003). The Alzheimer’s Aβ peptide 
exhibits copper-dependent oscillations in NADH oxidase ac-
tivity similar to that of tNOX and the mouse prion also with a 
24 min period length (Morré and Morré 2003). The Aβ pep-
tide both lacks a cysteine and is unable to carry out disulfide-
thiol interchange. α-Synuclein also has a copper-dependent 
and oscillating NADH oxidase activity but the period length 
is 54 min. The α-synuclein has not been evaluated for disul-
fide-thiol interchange activity. These various relationships 
are summarized in Table 1. Complete amino acid sequences 
are known for each of the proteins listed in Table 1. There is 
virtually no sequence similarity. Even though all bind copper, 
the copper binding strategies differ. For tNOX, the putative 
copper site is a HVH and a 3rd H downstream conserved with 
superoxide dismutase. The mouse prion utilizes the hexa 
repeats. For α-synuclein and Alzheimer’s Aβ, a combination 
of tyrosines are utilized. It is unlikely that CNOX will exhibit 
substantial sequence similarity to tNOX based on data base 
searches and antisera specificity. Yet all examples in Table 1 
bind adenine nucleotide (NADH) although the amino acid 
sequences within the putative binding regions differ. 
Possibly the best source of a new set of tools to under-
stand ECTO-NOX periodicity and oxidative function is now 
provided by the Alzheimer’s Aβ peptide of 43 amino acids 
in length. The copper site is known and a putative NADH 
site is found near the C-terminus as in tNOX in the vicinity 
of M-35. We are hopeful that a detailed analysis of various 
modifications within the Aβ peptide will begin to shed light 
on how ECTO-NOX proteins keep time and carry out their 
oxidative functions.
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